Shaun Kuoni, MD
Pain Medicine · Hammond, LANPI 1992159743
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,256 of the $3,134 with a category attached, or 72.0%. 25 manufacturers reported payments, led by Relievant Medsystems, Inc. at 34.6% of the total. Reporting peaked in 2022 at $1,311 and has fallen 50.4% since, to $650 in 2025. That places this record below the midpoint for pain medicine clinicians in LA, where the typical reported total is $3,650.
Across 89 payments — averaging $35.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$1K
- Abbott$269
- Medtronic$267
- Boston Scientific$232
- Valinor Pharma, LLC$216
- AbbVie$156
- plus $911 from 19 others
What the payments were for
- Travel & lodging$79025%
- Food & beverage$2,25672%
- Education$883%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 7 | $1,083 |
| Abbott | 7 | $269 |
| Medtronic | 7 | $267 |
| Boston Scientific | 8 | $232 |
| Valinor Pharma, LLC | 11 | $216 |
| AbbVie | 8 | $156 |
| Collegium Pharmaceutical, Inc. | 8 | $153 |
| Spinal Simplicity, LLC | 2 | $137 |
| Sanofi | 4 | $101 |
| Merz Pharmaceuticals, LLC | 3 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $92 |
| Genentech USA, Inc. | 3 | $52 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| SPR Therapeutics, Inc | 2 | $32 |
| Nevro Corp. | 2 | $31 |
| Avanos Medical | 1 | $28 |
| Biotronik NRO, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
| Biogen | 1 | $19 |
| Amgen | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| ALON Medical Technology | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,865
- HA MINUTEMAN G3-R$121
- ETERNA$116
- Proclaim IPG$101
How this compares
$3,134 in reported general payments places this provider in the 45th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 124 | $111,568 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,766 | $48,834 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,280 | $48,512 |
| Buprenorphine | 158 | $44,860 |
| Xtampza ErOxycodone Myristate | 23 | $19,008 |
| MovantikNaloxegol Oxalate | 37 | $17,429 |
| Pregabalin | 817 | $11,843 |
| Gabapentin | 839 | $8,845 |
| Lidocaine | 69 | $5,357 |
| Diclofenac Sodium | 190 | $5,116 |
| Oxycodone Hcl | 272 | $3,815 |
| Celecoxib | 213 | $3,430 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 117 | $3,212 |
| Tramadol Hcl | 412 | $2,731 |
| Methocarbamol | 291 | $2,637 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $153 | $130,576147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 97 pain medicine providers in Louisiana.
Other pain medicine in Hammond
- Mohamed ElkershHammond$12K
- William ChiangHammond$6K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Gassan ChaibanLake Charles$30K
- Yashar EshraghiNew Orleans$22K
- Prathima AnandiShreveport$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.